Complete response letterLetter dated July 21, 2026
Complete response letter to Apiject Systems Corp.
NDA 219107
FDA issued a complete response letter to Apiject Systems Corp. for NDA 219107, dated July 21, 2026.
On the record
- Applicant
- Apiject Systems Corp.
- Application
- NDA 219107
- Letter dated
- 2026-07-21
- FDA center
- Center for Drug Evaluation and Research
The full record
An account shows the text of the letter: the deficiencies FDA listed.
What a complete response letter is
A complete response letter tells an applicant that FDA has finished reviewing a drug or biologic application and will not approve it in its present form. The letter describes the deficiencies FDA found. FDA began publishing these letters in July 2025.
More
Watch Apiject Systems Corp
A free account shows the last 7 days of every FDA, SEC and ClinicalTrials.gov source. Pro adds a watchlist: one email when FDA acts on a company you name.
From openFDA complete response letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Apiject Systems Corp. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.